Analyst Price Targets — VYGR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 12, 2025 10:33 am | Yanan Zhu | Wells Fargo | $10.00 | $3.81 | TheFly | Voyager Therapeutics price target lowered to $10 from $12 at Wells Fargo |
| November 13, 2024 3:53 pm | Jay Olson | Oppenheimer | $18.00 | $6.92 | StreetInsider | Oppenheimer Reiterates Outperform Rating on Voyager Therapeutics (VYGR) |
| September 25, 2024 6:53 am | Jack Allen | Robert W. Baird | $18.00 | $6.04 | StreetInsider | Baird Reiterates Outperform Rating on Voyager Therapeutics (VYGR) |
| May 14, 2024 6:47 am | Laura Chico | Wedbush | $8.00 | $8.48 | StreetInsider | Voyager Therapeutics (VYGR) PT Lowered to $8 at Wedbush |
| January 2, 2024 1:08 pm | Jim Birchenough | Wells Fargo | $14.00 | $9.00 | StreetInsider | Wells Fargo Upgrades Voyager Therapeutics (VYGR) to Overweight |
| May 10, 2023 3:18 pm | Joon Lee | Truist Financial | $18.00 | $9.88 | Benzinga | Voyager Therapeutics' Seasoned Management And Leading Adeno-Associated Virus Capsid Platform Impress Bullish Analyst |
Latest News for VYGR
- Data presented as Developing Topics poster at AAIC 2026 - LEXINGTON, Mass., July 13, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today presented six-month good laboratory practice (GLP) toxicology data for VY1706, the Company's investigational gene therapy targeting intracellular and extracellular tau…
On the June 30 episode of Mad Money, a 23-year-old caller named Jackson from Iowa asked Jim Cramer about Voyager Therapeutics (NASDAQ:VYGR), a clinical-stage gene therapy company he wanted to hold for the long haul.
LEXINGTON, Mass. , June 29, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced a Developing Topics (late-breaking) poster presentation at the upcoming Alzheimer's Association International Conference (AAIC) taking place in London, July 12-15, 2026.
LEXINGTON, Mass., June 29, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced a Developing Topics (late-breaking) poster presentation at the upcoming Alzheimer's Association International Conference (AAIC) taking place in London, July 12-15, 2026. The Developing Topics poster presentation will…
Voyager Technologies Chairman and CEO Dylan Taylor joins ‘Mornings with Maria' to discuss SpaceX's record-breaking IPO, the rise of the space economy and Voyager's first year as a public company. #foxbusiness #morningswithmaria 0:00 SpaceX's Record-Breaking $75 Billion IPO Debut 1:07 Why Investors Are Betting Big on the Space Economy 3:15 Starlab's Race to Replace the International Space Station 5:23 The Growing…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VYGR.
U.S. House Trading
No House trades found for VYGR.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.